We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Interleukin-6 Antagonists in Critically-ill Covid-19 Patients (HEMOCOV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05218369
Recruitment Status : Not yet recruiting
First Posted : February 1, 2022
Last Update Posted : February 1, 2022
Information provided by (Responsible Party):
University of Pecs

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : February 1, 2023
Estimated Study Completion Date : August 31, 2023

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):